Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors

While head and neck squamous cell carcinomas (HNSCC) are marginally decreasing due to the reduction in exposure to the major risk factors, tobacco and alcohol, the incidence of high-risk human papillomavirus (HPV)-positive oropharynx squamous cell carcinomas (OPSCC), especially those in the tonsil a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stern, Peter L., Dalianis, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310271/
https://www.ncbi.nlm.nih.gov/pubmed/34202255
http://dx.doi.org/10.3390/v13071234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310271/
https://www.ncbi.nlm.nih.gov/pubmed/34202255
http://dx.doi.org/10.3390/v13071234

Ejemplares similares